9Weighted average disclosed price for brands of pharmaceutical items in Schedule 2

9 Weighted average disclosed price for brands of pharmaceutical items in Schedule 2

(a) For subsection 99ADB(4) of the Act, the weighted average disclosed price of a brand of pharmaceutical item specified in column 2 of an item in the table to Schedule 2 is the amount specified in column 3 of that table item.

(b) Subsection (a) applies in respect of a data collection period for a brand of pharmaceutical item ending on 30 September 2025.

Note: This instrument does not determine a reduction day for paragraph 99ADH(1)(aa) of the Act for a brand